Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
AKBA holding history
Akebia Therapeutics, Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKBA overviewAll 13F holders of AKBAFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −20,000−100.0% | Sold out | Holders |
| Q1 2022 | 20,000 | $14.0K | <0.1% | −80,000−80.0% | Reduced | Holders |
| Q4 2021 | 100,000 | $226.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 100,000 | $288.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2021 | 100,000 | $379.0K | 0.2% | +100,000 | New | Holders |